Evidence map›Paper›PMID 42682314›Full record

ArticleInternational journal of surgery (London, England)2026

COMMD9-regulated endothelial cell abnormality-induced hypercoagulability is associated with Budd-Chiari syndrome.

Hairun Gan, Jia Li, Xiaodi Zheng, Xinyan Hu, Leye Yan, Bing Li, Luting Li, Bin Zhou, Maoheng Zu, Ni Zhao and 13 more

Abstract read
In one paragraph

Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Hairun GanCenter for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China.ORCID https://orcid.org/0000-0002-7944-8662
Jia LiBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Xiaodi ZhengCenter for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China.
Xinyan HuCenter for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China.
Leye YanCenter for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China.
Bing LiDepartment of Ophthalmology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China.
Luting LiCenter for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China.
Bin ZhouCenter for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China.
Maoheng ZuThe Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province, China.
Ni ZhaoCenter for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China.
Jianan HeCenter for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China.
Huijie WangCenter for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China.
Meihua TanBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Wei LiBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Si ZhouBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Jiangguo ZhangBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Shuai LiBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Sihu XuBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Lijian ZhaoBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Xiaolong QiCHESS Center, Institute of Portal Hypertension, Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu Province, China.
Jing ZhangGuangdong Provincial People's Hospital, Guangzhou, Guangdong Province, China.
Hao XuThe Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province, China.
Pengfei PangCenter for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Budd-Chiari syndrome (BCS) presents diagnostic and treatment challenges owing to its insidious onset. Genetic variants associated with BCS vary geographically; in Asian populations, the condition is primarily caused by membranous obstruction composed of endothelial cells (ECs). A better understanding of the genetic pathogenesis of membranous BCS may offer new insights into disease mechanisms. Methods: This study employed whole-exome sequencing to identify candidate genes responsible for EC abnormalities in 485 patients with membranous BCS and 329 patients with vascular malformations (VaMs). Functional investigations were conducted to validate the selected genes Results: Whole-exome data revealed that the frequency of variants in the vascular function-related Conclusions: These findings indicate that multiple rare genetic variants, particularly in

Indexed as

Budd–Chiari syndromeCOMMD9endothelial cellsKLHDC2whole-exome sequencing

Identifiers

PMID42682314
PMCPMC13249327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.